investordatabase.org

Venrock

venrock.com Direct investor

Venrock is a venture capital firm with two investment programs: a traditional venture capital program focused on early stage investing in healthcare and technology companies, and a later-stage healthcare program that invests in small capitalization public companies and late-stage private healthcare companies. The firm is headquartered in Palo Alto, California, with an additional office in New York.

Venrock is a venture capital firm headquartered in Palo Alto, United States. It invests directly in companies, from seed to Series B, in technology, healthcare, AI and consumer.

“Venrock consists of two separate investment programs: a traditional venture capital program, focused on early stage investing in healthcare and technology companies; and a later-stage healthcare program, which implements a venture capital-like long-term approach to investment opportunities in small capitalization public companies and late-stage private healthcare companies.”

— Venrock, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed – Series B
Headquarters
Palo Alto, United States
Sectors
Technology, Healthcare, AI, Consumer, Crypto, Cybersecurity, Defense & Aerospace, FinTech

Team, as Venrock publishes it

  • Brian Ascher Partner
  • Shelby Barada VHCP
  • Ethan Batraski Partner
  • Nick Beim Partner
  • Racquel Bracken Partner
  • Phil DiGiacomo Partner
  • Katie Donahue VHCP
  • Andrew Gottesdiener VHCP
  • Ken Greenberg VHCP
  • Manjinder Kandola VHCP
  • Kevin Kao VHCP
  • Lesley Kelly Head of Trading

Names and roles exactly as listed on venrock.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Venrock publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 12392 · added 2026-09-29 · link last verified 2026-09-29 · confidence high

Similar investors

Listed under